Date published: 2025-12-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

N-Nitroso-N-methyl-4-aminobutyric Acid (CAS 61445-55-4)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
4-(Methylnitrosoamino)butanoic Acid; N-Methyl-N-(3-carboxypropyl)nitrosamine; NMBA
Application:
N-Nitroso-N-methyl-4-aminobutyric Acid is a compound found in various tobacco types
CAS Number:
61445-55-4
Purity:
98%
Molecular Weight:
146.15
Molecular Formula:
C5H10N2O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

N-Nitroso-N-methyl-4-aminobutyric acid is a chemical compound often utilized in the field of chemical research for its role as a nitrosamine. Researchers investigate the mechanisms by which nitrosamines like N-Nitroso-N-methyl-4-aminobutyric acid may cause alterations at a cellular level, particularly focusing on its interactions with biomolecules. Studies involving this chemical frequently explore its impact on DNA, where it may induce mutations due to its alkylating properties. In addition to genetic studies, N-Nitroso-N-methyl-4-aminobutyric acid is used to understand the biochemical pathways of nitrosation reactions, as its formation and stability are significant in environmental chemistry. The compound also serves as a reference substance in analytical chemistry to develop detection methods for nitrosamine contaminants in various environments.


N-Nitroso-N-methyl-4-aminobutyric Acid (CAS 61445-55-4) References

  1. Hypertension Hot Potato - Anatomy of the Angiotensin-Receptor Blocker Recalls.  |  Byrd, JB., et al. 2019. N Engl J Med. 380: 1589-1591. PMID: 30865819
  2. Nitrosamine Impurities in Angiotensin Receptor Blockers.  |  Shephard, EA. and Nawarskas, JJ. 2020. Cardiol Rev. 28: 262-265. PMID: 32467427
  3. A Cautionary Tale: Quantitative LC-HRMS Analytical Procedures for the Analysis of N-Nitrosodimethylamine in Metformin.  |  Yang, J., et al. 2020. AAPS J. 22: 89. PMID: 32613429
  4. Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.  |  Ray, A., et al. 2020. Glob Cardiol Sci Pract. 2020: e202025. PMID: 33426042
  5. Analytical lifecycle management for comprehensive and universal nitrosamine analysis in various pharmaceutical formulations by supercritical fluid chromatography.  |  Schmidtsdorff, S., et al. 2021. J Pharm Biomed Anal. 197: 113960. PMID: 33626447
  6. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.  |  Bharate, SS. 2021. J Med Chem. 64: 2923-2936. PMID: 33706513
  7. Estimated Cancer Risks Associated with Nitrosamine Contamination in Commonly Used Medications.  |  Li, K., et al. 2021. Int J Environ Res Public Health. 18: PMID: 34574388
  8. Risk assessment for nitrosated pharmaceuticals: A future perspective in drug development.  |  Schmidtsdorff, S., et al. 2022. Arch Pharm (Weinheim). 355: e2100435. PMID: 35088435
  9. A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans.  |  Chang, SH., et al. 2020. J Food Drug Anal. 28: 292-301. PMID: 35696119
  10. A Multi-Analyte LC-MS/MS Method for Determination and Quantification of Six Nitrosamine Impurities in Sartans like Azilsartan, Valsartan, Telmisartan, Olmesartan, Losartan and Irbesartan.  |  Gopireddy, RR., et al. 2022. J Chromatogr Sci.. PMID: 35830866
  11. Determination of Genotoxic Impurity N-Nitroso-N-methyl-4-aminobutyric Acid in Four Sartan Substances through Using Liquid Chromatography-Tandem Mass Spectrometry.  |  Xie, B., et al. 2022. Molecules. 27: PMID: 36364326
  12. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.  |  Zhang, J., et al. 2022. J Pharm Sci.. PMID: 36509171
  13. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.  |  Monteiro, MA., et al. 2023. J Pharm Sci.. PMID: 36657719
  14. Identification and occurrence of two new N-nitrosamino acids in tobacco products: 3-(N-nitroso-N-methylamino)propionic acid and 4-(N-nitroso-N-methylamino)butyric acid.  |  Ohshima, H., et al. 1985. Cancer Lett. 26: 153-62. PMID: 3978605

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

N-Nitroso-N-methyl-4-aminobutyric Acid, 10 mg

sc-212252
10 mg
$410.00

N-Nitroso-N-methyl-4-aminobutyric Acid, 25 mg

sc-212252A
25 mg
$816.00

N-Nitroso-N-methyl-4-aminobutyric Acid, 1 g

sc-212252C
1 g
$20400.00